The company is mainly engaged in the manufacture and sale of biochemical pharmaceuticals, technology solutions services and real estate development. Its key biochemical pharmaceutical products include clindamycin phosphate, potassium magnesium aspartate and water-soluble vitamins. The company has a number of subsidiaries, namely Shandong Huatai Pharmaceutical Co. Ltd, Shenzhen Wuzhou Medicine Co. Ltd, Wuhan Software Co. Ltd and Beijing Guonong Zhiye Co. Ltd. In 2007, Shenzhen Cau acquired an additional 33.33% stake in Beijing Guonong Zhiye Co. Ltd bringing its total holdings in that company to 99%.